The development marks the fifth approved indication of the drug since October 2023.
The US Food and Drug Administration has approved bimekizumab, a humanized interleukin -17A and IL-17F antagonist, for the treatment of adults with moderate to severe hidradenitis suppurativa .improved the signs and symptoms of disease compared with placebo at week 16 and were sustained to week 48, according to afrom UCB, the drug’s manufacturer.
The company noted that bimekizumab is the first and only approved medicine designed to selectively inhibit IL-17F in addition to IL-17A. According to the, the recommended dosing for patients with HS is 320 mg administered by subcutaneous injection at week 0, 2, 4, 6, 8, 10, 12, 14, and 16, then every 4 weeks thereafter.
“The approval of bimekizumab for moderate-to-severe HS is tremendous news for people living with HS” and the clinicians who care for them,“It is exciting that we already have two-year trial data for bimekizumab in HS and can see that bimekizumab raises the bar in terms of depth and durability of response that we can expect to see in our patients,” she added.
U.S. Food And Drug Administration United States Food And Drug Administration Fda Skin And Soft Tissue Infection Ankylosing Spondylitis Rheumatoid Spondylitis Rheumatoid Arthritis Of The Spine Bechterew's Disease Bechterew Syndrome Marie Strumpell Disease Marie Struempell Disease Spondyloarthritis Spondylosis Pregnancy Pregnant Axial Spondyloarthritis Axspa
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves Pfizer's RSV vaccine for adults at increased risk of the diseaseThe U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease.
Read more »
US FDA Approves Journey Medical's Drug for Long-term Skin ConditionJourney Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term skin condition called rosacea, sending the...
Read more »
Bimekizumab Offers Durable and Consistent Benefits in HSPatients with moderate to severe HS experienced sustained symptomatic and quality-of-life improvements with the monoclonal antibody bimekizumab, reveals 2-year trial data.
Read more »
California approves tighter rules for low carbon fuels policyCalifornia approves tighter rules for low carbon fuels policy
Read more »
CPS board approves resolution seeking to keep Acero charter schools openCPS board approves resolution seeking to keep Acero charter schools open
Read more »
New York transit approves $9 Manhattan congestion charge to start Jan. 5New York transit approves $9 Manhattan congestion charge to start Jan. 5
Read more »